Radiofluorination and biological evaluation of N-aryl-oxadiazolyl-propionamides as potential radioligands for PET imaging of cannabinoid CB2 receptors

Overview of attention for article published in Organic and Medicinal Chemistry Letters, September 2013

Altmetric Badge

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 19 Mendeley

Summary Dimensions citations

So far, Dimensions has found 21 publications that cite this research output.

21

The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.

Synthesis, Structure–Activity Relationships, Radiofluorination, and Biological Evaluation of [18F]RM365, a Novel Radioligand for Imaging the Human Cannabinoid Receptor Type 2 (CB2R) in the Brain with PET

Article in Journal of Medicinal Chemistry (October 2023)

Discovery of 4‑(1,2,4-Oxadiazol-5-yl)azepan-2-one Derivatives as a New Class of Cannabinoid Type 2 Receptor Agonists for the Treatment of Inflammatory Pain

Article in Journal of Medicinal Chemistry (February 2023)

Rational drug design of CB2 receptor ligands: from 2012 to 2021

Article in RSC Advances (December 2022)